Retinopathy of prematurity.
OBJECTIVE
This review highlights recent advances in basic science and clinical research on retinopathy of prematurity (ROP).


RESULTS
The modern concept of ROP pathophysiology is discussed, as are studies investigating anti-angiogenic agents for treatment. Results of the largest clinical trials are summarized. Current screening criteria, potential modifications to them, and telephotoscreening are discussed.


CONCLUSIONS
ROP is a challenging and involving area of pediatric ophthalmology.
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D007231:Infant, Newborn; D008403:Mass Screening / Q000379:methods; D012178:Retinopathy of Prematurity / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology*; D017216:Telemedicine
D020533:Angiogenesis Inhibitors